» Articles » PMID: 25413413

Contouring Variations and the Role of Atlas in Non-small Cell Lung Cancer Radiation Therapy: Analysis of a Multi-institutional Preclinical Trial Planning Study

Overview
Publisher Elsevier
Specialties Oncology
Radiology
Date 2014 Nov 22
PMID 25413413
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To quantify variations in target and normal structure contouring and evaluate dosimetric impact of these variations in non-small cell lung cancer (NSCLC) cases. To study whether providing an atlas can reduce potential variation.

Methods And Materials: Three NSCLC cases were distributed sequentially to multiple institutions for contouring and radiation therapy planning. No segmentation atlas was provided for the first 2 cases (Case 1 and Case 2). Contours were collected from submitted plans and consensus contour sets were generated. The volume variation among institution contours and the deviation of them from consensus contours were analyzed. The dose-volume histograms for individual institution plans were recalculated using consensus contours to quantify the dosimetric changes. An atlas containing targets and critical structures was constructed and was made available when the third case (Case 3) was distributed for planning. The contouring variability in the submitted plans of Case 3 was compared with that in first 2 cases.

Results: Planning target volume (PTV) showed large variation among institutions. The PTV coverage in institutions' plans decreased dramatically when reevaluated using the consensus PTV contour. The PTV contouring consistency did not show improvement with atlas use in Case 3. For normal structures, lung contours presented very good agreement, while the brachial plexus showed the largest variation. The consistency of esophagus and heart contouring improved significantly (t test; P < .05) in Case 3. Major factors contributing to the contouring variation were identified through a survey questionnaire.

Conclusions: The amount of contouring variations in NSCLC cases was presented. Its impact on dosimetric parameters can be significant. The segmentation atlas improved the contour agreement for esophagus and heart, but not for the PTV in this study. Quality assurance of contouring is essential for a successful multi-institutional clinical trial.

Citing Articles

prospective acceptability benchmarking from the Contouring Collaborative for Consensus in Radiation Oncology crowdsourced initiative for multiobserver segmentation.

Lin D, Wahid K, Nelms B, He R, Naser M, Duke S J Med Imaging (Bellingham). 2023; 10(Suppl 1):S11903.

PMID: 36761036 PMC: 9907021. DOI: 10.1117/1.JMI.10.S1.S11903.


Clinical validation of deep learning algorithms for radiotherapy targeting of non-small-cell lung cancer: an observational study.

Hosny A, Bitterman D, Guthier C, Qian J, Roberts H, Perni S Lancet Digit Health. 2022; 4(9):e657-e666.

PMID: 36028289 PMC: 9435511. DOI: 10.1016/S2589-7500(22)00129-7.


Dose-volume-based evaluation of convolutional neural network-based auto-segmentation of thoracic organs at risk.

Johnston N, De Rycke J, Lievens Y, van Eijkeren M, Aelterman J, Vandersmissen E Phys Imaging Radiat Oncol. 2022; 23:109-117.

PMID: 35936797 PMC: 9352974. DOI: 10.1016/j.phro.2022.07.004.


Real-world analysis of manual editing of deep learning contouring in the thorax region.

Vaassen F, Boukerroui D, Looney P, Canters R, Verhoeven K, Peeters S Phys Imaging Radiat Oncol. 2022; 22:104-110.

PMID: 35602549 PMC: 9115320. DOI: 10.1016/j.phro.2022.04.008.


Challenges in the target volume definition of lung cancer radiotherapy.

Mercieca S, Belderbos J, Van Herk M Transl Lung Cancer Res. 2021; 10(4):1983-1998.

PMID: 34012808 PMC: 8107734. DOI: 10.21037/tlcr-20-627.


References
1.
Yamamoto M, Nagata Y, Okajima K, Ishigaki T, Murata R, Mizowaki T . Differences in target outline delineation from CT scans of brain tumours using different methods and different observers. Radiother Oncol. 1999; 50(2):151-6. DOI: 10.1016/s0167-8140(99)00015-8. View

2.
Steenbakkers R, Duppen J, Fitton I, Deurloo K, Zijp L, Comans E . Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. Int J Radiat Oncol Biol Phys. 2005; 64(2):435-48. DOI: 10.1016/j.ijrobp.2005.06.034. View

3.
Rosewall T, Bayley A, Chung P, Le L, Xie J, Baxi S . The effect of delineation method and observer variability on bladder dose-volume histograms for prostate intensity modulated radiotherapy. Radiother Oncol. 2011; 101(3):479-85. DOI: 10.1016/j.radonc.2011.06.039. View

4.
Fitton I, Steenbakkers R, Gilhuijs K, Duppen J, Nowak P, Van Herk M . Impact of anatomical location on value of CT-PET co-registration for delineation of lung tumors. Int J Radiat Oncol Biol Phys. 2007; 70(5):1403-7. DOI: 10.1016/j.ijrobp.2007.08.063. View

5.
Cattaneo G, Reni M, Rizzo G, Castellone P, Ceresoli G, Cozzarini C . Target delineation in post-operative radiotherapy of brain gliomas: interobserver variability and impact of image registration of MR(pre-operative) images on treatment planning CT scans. Radiother Oncol. 2005; 75(2):217-23. DOI: 10.1016/j.radonc.2005.03.012. View